Stage III Ovarian Epithelial Cancer Completed Phase 1 Trials for Denileukin diftitox (DB00004)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00357448Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube CancerTreatment